Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study

Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study

Introduction: Thromboelastography (TEG) provides a global assessment of haemostasis and is potentially applicable to liver disease. The present study aimed to explore the utility of TEG for the evaluation of patients with chronic viral liver disease, which has previously not been investigated. Metho...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ying Di, Jialu Li, Chunjuan Ye, Zheng Wang, Qianqian Zhu
Format:	Article
Language:	English
Published:	Wolters Kluwer – Medknow Publications 2024-08-01
Series:	Singapore Medical Journal
Subjects:	chronic viral liver disease liver resections thromboelastography
Online Access:	https://journals.lww.com/10.4103/singaporemedj.SMJ-2021-404
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigation of hemostasis by thromboelastography in the patient with liver cirrhosis (Clinical case)
by: Ye. L. Bulanova, et al.
Published: (2011-12-01)

Mediators of intercellular interactions and histological signs of chronic viral liver disease
by: P. V. Koroy, et al.
Published: (2014-11-01)

Activity of tissue enzymes of the liver and peripheral blood lymphocytes at children with chronic hepatitis B
by: V. G. Bulygin, et al.
Published: (2010-02-01)

Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations)
by: A. A. Lavreniuk, et al.
Published: (2024-12-01)

Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases status
by: Xuxiazi Zou, et al.
Published: (2025-02-01)

Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
by: Qiyao Wei, et al.
Published: (2025-02-01)

Potential of albumin dialysis at terminal liver failure in patients with chronic liver diseases
by: O. E. Nikiforova, et al.
Published: (2010-08-01)

Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2023-05-01)

Modern treatment methods of patients with liver metastases of colorectal cancer
by: Ye. N. Grebenkin, et al.
Published: (2013-07-01)

Nutritional assessment using subjective global assessment identifies energy malnutrition and predicts mortality in patients with liver cirrhosis
by: Takao Miwa, et al.
Published: (2025-02-01)

Screening investigation of patients with diffuse liver diseases
by: I. Yu. Pirogova
Published: (2010-06-01)

Treatment of biliary cysts of the liver and polycystic liver disease: a surgical view
by: M. P. Kochieva, et al.
Published: (2010-02-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

A retrospective analysis of outcomes and complications of living- and deceased-donor split-liver transplantation in Johannesburg, South Africa
by: R Crawford, et al.
Published: (2024-04-01)

Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis
by: Pischtaz Adel Tariparast, et al.
Published: (2025-02-01)

Cholestasis in Chronic Liver Disease and the Role of Ademetionine in its Treatment (Literature Review and Expert Panel Resolution)
by: K. L. Raikhelson, et al.
Published: (2024-10-01)

Lipid spectrum in liver cells and peripheral blood lymphocytes at children with chronic hepatitis B
by: V. G. Bulygin
Published: (2011-05-01)

Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases
by: M. V. Mayevskaya, et al.
Published: (2019-09-01)

von Willebrand factor polymorphism (rs1063856) as a risk factor for portal vein thrombosis in chronic liver diseases
by: Isis Samy Bedira, et al.
Published: (2025-02-01)

Leading causes of fever in patients with liver function disorders
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center
by: Ye. N. Bessonova, et al.
Published: (2013-12-01)

Successful living donor liver transplantation of the left lateral sector with simultaneous atypical resection of the S2 for focal nodular hyperplasia
by: R. T. Rzayev, et al.
Published: (2022-05-01)

Wits Transplant Unit Annual Report 2022: Adult and paediatric liver transplantation
by: E U Wessels, et al.
Published: (2024-04-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Viral hepatitis B epidemiology in Sakha republic (Yakutia)
by: S. I. Semenov, et al.
Published: (2015-09-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Managing Liver Cirrhosis: a Multidisciplinary Approach
by: V. M. Durleshter, et al.
Published: (2020-09-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Complex application of mathematical methods in diagnostics of diffuse liver diseases
by: I. Yu. Pirogova, et al.
Published: (2011-02-01)

Principles of effective out-patient diagnostics of diffuse liver diseases
by: Komova A. G., et al.
Published: (2014-11-01)

Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
by: R. M. Kurabekova, et al.
Published: (2020-09-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Liver cystic echinococcosis: A retrospective study on the demographics and clinical profile of patients managed at a single tertiary institution in central Eastern Cape Province, South Africa
by: A Govindasamy, et al.
Published: (2024-05-01)

Efficacy of silymarinum at chronic diffuse liver diseases
by: A. V. Matvieiev, et al.
Published: (2011-09-01)

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
by: Núria Granel, et al.
Published: (2025-02-01)

Parameters of the Component Composition of the Body and Their Relationship with the Development of Ascites in Liver Cirrhosis
by: Yu. O. Zharikov, et al.
Published: (2024-08-01)

Hypercoagulation syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2014-12-01)

Demographics, aetiology and outcome of paediatric acute liver failure in Singapore
by: Fang Kuan Chiou, et al.
Published: (2022-11-01)